MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0013847
Leemedi Pharma Private Limited
Leemedi Pharma Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.49 Lakh
▲ 7% YoY
Net loss · FY 2025
₹1.69 Lakh
Net margin -5.7%
EBITDA · FY 2025
₹46,482
EBITDA margin 1.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Leemedi Pharma Private Limited
Data last updated:
Leemedi Pharma Private Limited is a private limited company based in Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 28 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U37100DL2013PTC250006. Its GSTIN is 07AACCL4499F1ZA (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manas Das and Beejayata Ray.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. F – 202 Khasra No – 666 2nd Floor Vill. Basai Darapur Nr. Balmiki Mandir Sudhar, Shan Park, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.49 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹1.69 Lakh (net margin -5.7%) and EBITDA of ₹46,482 (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 6% over five years.
Leemedi Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0013847). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Leemedi Pharma Private Limited
CIN U37100DL2013PTC250006
Registration Number 250006
Incorporation Date 28 March 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0013847
Key People
Manas Das Director Beejayata Ray Director Recognitions & Rankings of Leemedi Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No. F – 202 Khasra No – 666 2nd Floor Vill. Basai Darapur Nr. Balmiki Mandir Sudhar, Shan Park, Delhi, India – 110015
- IndustryHealthcare, Medical & Laboratory Equipment
Comprehensive company report
Leemedi Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Leemedi Pharma Private Limited
The main business activity of Leemedi Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Leemedi Pharma Private Limited FY 2025 filings available
Leemedi Pharma Private Limited reported revenue of ₹29.49 Lakh (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹29.49 Lakh ▲ 7%
Net loss · FY 2025
₹1.69 Lakh margin -5.7%
EBITDA · FY 2025
₹46,482 margin 1.6%
Compounded Annual Growth Rate (CAGR) of Leemedi Pharma Private Limited
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 1%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 73%
3 years · compounded
▼ 50%
5 years · compounded
▼ 29%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 7% growth in the latest year. EBITDA fell 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Leemedi Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹46,482 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.69 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Leemedi Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -5.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Leemedi Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Leemedi Pharma Private Limited
Leemedi Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manas Das | Director | 28 Mar 2013 | 13 Years 6 Months | Current |
| Beejayata Ray | Director | 28 Mar 2013 | 13 Years 6 Months | Current |
Peer Comparison of Leemedi Pharma Private Limited
Leemedi Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Trios Pharmaceuticals Private Limited | ₹29.68 Lakh (FY 2019) | •••• | •••• | -19.0% | •••• | New Delhi, Delhi, India |
| Mikado Laboratories Private Limited | ₹29.66 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Mathura, Uttar Pradesh, India |
| Nan Pharma Private Limited | ₹29.52 Lakh (FY 2022) | •••• | •••• | -1.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Xpert Scientific Private Limited | ₹29.52 Lakh (FY 2023) | •••• | •••• | -29.0% | •••• | Vasai, Maharashtra, India |
| Rezstar Pharmaceutical Private Limited | ₹29.5 Lakh (FY 2024) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Leemedi Pharma Private Limited this company | ₹29.49 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Delhi, India |
| Octaglo Laboratories Private Limited | ₹29.41 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Peppyskinoid Private Limited | ₹29.38 Lakh (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Ayushine Better Concept Wellcare Private Limited | ₹29.36 Lakh (FY 2025) | •••• | •••• | -42.0% | •••• | Sanand, Gujarat, India |
| Rave Pharmaceuticals Private Limited | ₹29.35 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Uttar Pradesh, India |
| Amro Biotech Private Limited | ₹29.35 Lakh (FY 2025) | •••• | •••• | 296.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Leemedi Pharma by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Leemedi Pharma Private Limited
Leemedi Pharma Private Limited is audited by Goel Tripathy & Co. for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Goel Tripathy & Co. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Leemedi Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Leemedi Pharma Private Limited
Leemedi Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Leemedi Pharma Private Limited
Employment history and EPFO contributions of people linked to Leemedi Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Leemedi Pharma Private Limited
Leemedi Pharma Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Chinmaya Chiranjibi Samal ceased to be Director on 12 Jun 2015.
AGM
Leemedi Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Leemedi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Chinmaya Chiranjibi Samal ceased to be Director.
Appointed
Beejayata Ray was appointed as Director.
Appointed
Manas Das was appointed as Director.
Incorporation
28 Mar 2013
Leemedi Pharma Private Limited was registered on 28 Mar 2013 with Roc Delhi & aged 13 years 6 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Leemedi Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Leemedi Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Leemedi Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Leemedi Pharma Private Limited
Leemedi Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCL4499F1ZA | Delhi | Active | 01 Jul 2017 |
| 21AACCL4499F1ZK | Odisha | Active | 27 Jan 2024 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Leemedi Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leemedi Pharma Private Limited
Leemedi Pharma is an active private limited company based in Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 28 March 2013 (13+ years old) and is registered under CIN U37100DL2013PTC250006.
Leemedi Pharma reported revenue of ₹29.49 Lakh for FY 2025 (up 7% YoY).
Leemedi Pharma has 2 current directors:
- Manas Das - Director
- Beejayata Ray - Director
Leemedi Pharma reported a net loss of ₹1.69 Lakh (net margin -5.7%) and EBITDA of ₹46,482 (EBITDA margin 1.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Leemedi Pharma is 1% over three years and 6% over five years. In the latest year (FY 2025) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Leemedi Pharma is 07AACCL4499F1ZA, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 21AACCL4499F1ZK (Odisha).
The CIN (Corporate Identification Number) of Leemedi Pharma is U37100DL2013PTC250006. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leemedi Pharma was incorporated on 28 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Leemedi Pharma by revenue are Trios Pharmaceuticals Private Limited, Mikado Laboratories Private Limited, Nan Pharma Private Limited, Xpert Scientific Private Limited, Rezstar Pharmaceutical Private Limited and 5 more, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment).
Chinmaya Chiranjibi Samal ceased to be Director on 12 Jun 2015. Beejayata Ray was appointed as Director on 28 Mar 2013. Manas Das was appointed as Director on 28 Mar 2013.
Yes, Leemedi Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0013847).